Everhart Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$797K Sell
2,646
-255
-9% -$76.9K 0.05% 213
2026
Q1
$960K Buy
2,901
+360
+14% +$123K 0.08% 182
2025
Q4
$1.01M Sell
2,541
-89
-3% -$39.4K 0.09% 153
2025
Q3
$1.2M Buy
2,630
+437
+20% +$178K 0.12% 114
2025
Q2
$715K Buy
2,193
+406
+23% +$112K 0.08% 179
2025
Q1
$483K Buy
1,787
+191
+12% +$49.1K 0.07% 212
2024
Q4
$376K Sell
1,596
-110
-6% -$28.9K 0.08% 231
2024
Q3
$469K Buy
1,706
+384
+29% +$100K 0.1% 201
2024
Q2
$321K Buy
+1,322
New +$209K 0.08% 217

Other funds holding ALNY